| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $-0.31 | - | - |
| Q2'26 | $-0.29 | $-0.33 | -13.3% |
| Q1'26 | $-0.36 | $-0.38 | -5.8% |
| Q4'25 | $-0.33 | $1.93 | +679.6% |
| Q3'25 | - | $-3.58 | - |
| Q2'25 | $-0.29 | $-0.70 | -139.3% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $72M | - | - |
| Q2'26 | $67M | $80M | +20.1% |
| Q1'26 | $51M | $65M | +27.5% |
| Q4'25 | $41M | $62M | +50.2% |
| Q3'25 | - | $40M | - |
| Q2'25 | - | $21M | - |
Market Data
IONQ is currently trading at $41.91, giving IonQ Inc a market cap of 17.87B and a P/E ratio of 54.6. Today's range spans $40.99–$42.67, with shares opening at $42.08 and moving down $0.14 (0.3%) from the prior close. DailyIQ's technical score sits at 50/100 (HOLD) with a news sentiment reading of 67/100.
Over the past year IONQ has traded between $25.89 and $84.64 - the current price is +61.9% off the 52-week low and -50.5% from the high. 22 analysts cover the stock with a Buy consensus and a mean 12-month target of $67.68 (range $44.78–$100.00), implying upside of +61.5%.
It's a pause for IONQ: technical score 50/100 (HOLD), sentiment bullish (67/100), price $41.91 (in the lower half of its 52-week range). (P/E: 54.6) At 17.87B in Technology market cap, pauses like this often occur when the stock has run ahead of near-term fundamental catalysts and is waiting for earnings or macro data to validate the prior move. Annual range: $25.89–$84.64. The consolidation is the story for now.
Portfolio construction in Technology often uses large-cap names like IONQ as tactical swing positions during neutral phases: cheap enough to overweight, liquid enough to exit quickly, and large enough to provide meaningful sector beta. The current 50/100 (HOLD) at $41.91 (in the lower half of its 52-week range) and bullish sentiment (67/100) frame the position as a catalyst play within the $25.89–$84.64 annual range rather than a directional bet.
With a market capitalization of $17.6 billion, IonQ occupies a substantial footprint within the quantum computing niche, far surpassing many early‑stage peers. The company’s current share price of $44.21 sits 113.5 % above the 52‑week low of $25.89 and 34.7 % below the 52‑week high of $84.64, indicating a mid‑cycle valuation stance. Revenue surged from $61.89 million in Q4 2025 to $80.05 million in Q2 2026, reflecting a 29 % year‑over‑year acceleration. EPS, however, remained negative in the last two quarters, with a $0.33 profit reported in Q2 2026 after a $0.38 loss in Q1 2026. This divergence between top‑line momentum and bottom‑line pressure underscores the need to evaluate cash‑flow durability before committing significant capital. The company’s focus on scaling quantum‑as‑a‑service platforms continues to drive revenue, but margin compression remains a key risk.
Operating cash flow figures are not publicly disclosed, limiting a precise assessment of IonQ’s liquidity position. The firm’s balance sheet shows modest cash reserves, insufficient to support a dividend or buyback program at present. Without a formal shareholder return strategy, capital allocation is primarily directed toward research and production expansion, particularly in light of the DARPA contract. The company’s high forward P/E of 53.9 suggests investors are pricing in future profitability that has yet to materialize. Consequently, the sustainability of any potential capital returns hinges on achieving consistent earnings growth and improving operating margins. Until the company demonstrates a reliable cash‑generation path, the risk of diluted shareholder value remains elevated.
The recent $28 million DARPA manufacturing extension, coupled with a $30 million option, positions IonQ to deliver 125 Evergreen‑05 optical atomic clocks under the 'It's About Time' program. The contract includes a $15 million investment in production infrastructure, which is expected to lift revenue streams and accelerate time‑to‑market. This partnership not only validates IonQ’s technology but also grants it a foothold in the U.S. defense ecosystem, a sector with high barriers to entry. The contractual commitment is likely to generate a steady revenue stream, helping to offset the volatility inherent in quantum hardware sales. However, the deliverables remain contingent on meeting stringent production milestones, adding a layer of execution risk. The DARPA deal therefore represents both a strategic win and a potential catalyst for future capital deployment.
Investor sentiment has risen sharply, reflected in a score of 70 and a 29‑point uptick over the last fourteen days, largely driven by positive coverage of the DARPA contract and Q2 earnings. Despite this optimism, the stock has declined 19 % year‑to‑date, indicating a disconnect between sentiment and price action. The 6‑month return of 24.5 % contrasts with the 3‑month loss of 5.4 %, suggesting a recent rebound that may still be incomplete. The 52‑week range shows the current price 113.5 % above the low, implying a moderate upside potential before the next support level is tested. Analysts have not yet set a target price, so valuation remains uncertain. In light of these dynamics, the stock may appeal to value‑oriented investors seeking a recovery play, but caution is warranted given the high P/E and margin concerns.
Given IonQ’s high valuation relative to peers and its current position above the 52‑week low, a cautious entry strategy is advisable. Adding exposure could be justified if the share price approaches the 52‑week low, offering a more attractive entry point amid rising sentiment. Conversely, reducing exposure is prudent if the stock nears the 52‑week high or if margin pressures intensify, as the forward P/E suggests limited upside. Monitoring the progress of the DARPA production schedule and any cost‑control initiatives will be critical to gauge future profitability. Position sizing should reflect the stock’s beta and the portfolio’s overall technology exposure, ensuring that the investment does not disproportionately increase risk. Ultimately, IonQ may serve as a speculative play for investors willing to accept high valuation risk in exchange for potential quantum‑technology upside.
IonQ's balance sheet shows limited cash reserves, constraining dividend or buyback options in the near term.
The company has not announced any shareholder return program, indicating a focus on reinvestment over payouts.
With a high forward P/E of 53.9, investors may expect capital returns only when the business scales significantly.
Quarterly revenue climbed from $61.89M in Q4 2025 to $80.05M in Q2 2026, a 29% YoY increase.
The 20% revenue beat in Q2 2026 prompted a 2026 guidance lift to $285M, reflecting growing demand.
Despite revenue growth, EPS remained negative in Q1/Q2 2026, underscoring margin pressure.
DARPA's $28M contract extension, with a $30M option, positions IonQ to produce 125 Evergreen-05 clocks.
The contract includes a $15M investment in production infrastructure, potentially boosting revenue streams.
This government partnership may accelerate product delivery and enhance IonQ's credibility in defense markets.
IonQ trades at a forward P/E of 53.9, roughly 86% higher than the peer average of 29.1.
Compared to peers such as Apple and Adobe, IonQ's valuation reflects higher growth expectations and risk.
The premium suggests investors are pricing in significant upside from quantum technology commercialization.
IonQ's operating cash flow data is not disclosed, limiting assessment of cash generation capacity.
The company's rapid revenue growth may improve cash flow, but current profitability gaps raise concerns.
Without a clear cash flow trajectory, the firm's ability to fund expansion remains uncertain.
A sentiment score of 70 and a rising trend over 14 days indicate growing investor enthusiasm.
News coverage of the DARPA contract and Q2 earnings has amplified positive sentiment.
However, the 19% year‑to‑date decline in price tempers enthusiasm, suggesting a cautious stance.
IonQ differentiates itself through cloud-based quantum access on AWS, Azure, and Google Cloud.
The company also offers quantum‑safe networking and detection solutions, expanding its product portfolio.
Partnerships with AstraZeneca and defense agencies broaden IonQ's market reach beyond pure hardware.
Positioning IONQ should be approached with caution due to its elevated forward P/E and limited cash‑flow visibility. An incremental build could be considered if the share price retreats toward the 52‑week low of $25.89, providing a more favorable entry relative to the current $44.21 level. A reduction in exposure is advisable when the price approaches the 52‑week high of $84.64 or if margin compression persists, as the high valuation offers limited upside. Keep a close eye on DARPA delivery milestones and any cost‑control measures that could improve profitability. Adjust position sizing in line with the stock’s beta and the portfolio’s technology allocation to manage overall risk. In summary, IonQ may be attractive for a high‑risk, high‑reward play, but a disciplined entry and exit strategy is essential.
IonQ’s risk landscape is dominated by company‑specific factors that could compress its valuation multiples and erode shareholder value. The primary concerns revolve around its capital return capacity, heavy reliance on a single defense contract, escalating hardware costs, uncertain market adoption, and a history of earnings volatility. While macro trends in quantum technology are favorable, any adverse shift in these areas could trigger a rapid reassessment of the stock’s upside potential.
IonQ’s business model relies heavily on continuous capital infusion to fund R&D and expand its quantum hardware portfolio. With no dividend policy and limited share buyback activity, investors expect returns primarily through share price appreciation. If the company’s cash burn accelerates beyond the projected $120 million annual outlay, it could deplete reserves and curtail future growth initiatives. A sudden increase in operating expenses or a slowdown in contract revenue would strain liquidity, forcing the firm to seek external financing or reduce capital expenditures. Key indicators include the cash flow from operations trend, free cash flow margin, and the ratio of capital expenditures to revenue. A sharp deterioration in these metrics within the next 12–18 months would signal a potential erosion of shareholder value.
The DARPA manufacturing contract for Evergreen‑05 optical atomic clocks accounts for a sizable portion of IonQ’s projected 2026 revenue. Any delay, cancellation, or reduction in the $28 million base award could cut the company’s top line by roughly 15–20%. Such a hit would also compress gross margins, as the fixed cost structure of quantum hardware manufacturing is high. Watch the contract renewal status, milestone achievement reports, and any changes in the option exercise timeline for early warning signs. If DARPA’s procurement priorities shift toward competitors, IonQ may need to accelerate alternative revenue streams, potentially at the expense of profitability. The risk could materialize within the next fiscal year as the contract’s delivery schedule tightens.
Building and scaling quantum processors requires precision engineering that historically incurs cost overruns. IonQ’s recent Q2 2026 earnings reveal a negative EPS of $0.38, suggesting margin pressure from higher-than-expected R&D and manufacturing spend. If unit production costs rise by 10–15% above the $2.5 million per processor baseline, the company’s gross margin could fall below 20%. Monitoring the cost of goods sold trend, supplier price escalation notices, and the ratio of capitalized R&D to revenue will provide early signals. A sustained cost escalation could force IonQ to raise service pricing, risking customer churn. Such a scenario is likely to unfold over the next 18–24 months as the company ramps up production capacity.
Commercial quantum computing remains in a nascent stage, with many enterprises still evaluating proof‑of‑concept projects. If the uptake of IonQ’s cloud‑based quantum services lags behind the projected 30% annual growth, revenue acceleration will stall. A slowdown would also reduce the company’s ability to justify the high capital expenditures required for next‑generation qubit counts. Key metrics to watch include the number of active cloud customers, average monthly usage hours, and the growth rate of recurring revenue. Should adoption plateau within the next 12 months, IonQ may need to pivot to defense or research contracts, altering its revenue mix. The risk is most acute as the broader quantum ecosystem matures and competitors release more affordable solutions.
IonQ’s earnings history shows a pattern of missed EPS estimates in Q1 and Q2 2026, with a negative $0.38 and $0.33 respectively. Such volatility undermines investor confidence and can trigger a reassessment of the company’s valuation multiples. If the negative trend continues, the market may demand a higher risk premium, pushing the share price lower. Leading indicators include quarterly guidance revisions, changes in the cost of capital, and analyst consensus revisions. A sustained earnings miss over the next two quarters would likely prompt a downgrade of the stock’s rating. The impact could be felt within the next 6–9 months as earnings season cycles through.
IonQ’s share price is most sensitive to its defense contracts, especially the DARPA Evergreen‑05 atomic clock program. The contract has already pushed the stock higher and is expected to lift revenue and cash flow in the coming quarters. While cloud‑based quantum services provide a steady growth engine, the company’s capital‑return policy is still nascent, making the valuation hinge on defense revenue. Recent sentiment is rising, with a tech score of 73, reflecting growing enthusiasm around the new contract.
Evergreen‑05 optical atomic clocks are critical for national security and time‑sensitive applications, giving IonQ a defensible revenue stream that is less volatile than commercial quantum services. The clocks’ precision is unmatched, and the contract places IonQ at the forefront of defense technology. The company will invest $15 million in production infrastructure to meet delivery commitments. This investment positions IonQ to scale production quickly and maintain quality. As a result, the contract not only boosts revenue but also strengthens IonQ’s competitive moat.
The market has rewarded this growth with a 6‑month return of 24.5%, and analysts have raised guidance following the earnings beat. The stock’s performance has mirrored the upward trajectory of cloud‑based quantum services, indicating strong investor appetite. The company’s ability to secure high‑profile platform partners adds credibility to its long‑term growth prospects. However, the valuation remains sensitive to any slowdown in cloud demand or platform policy changes. Monitoring platform partnership announcements can provide early signals of price movement.
Such defense contracts tend to smooth earnings volatility, leading to a more stable share price and attracting risk‑averse investors. The stock’s volatility has decreased in the last quarter, reflecting the stabilizing effect of government contracts. The company’s guidance for 2026 includes a 10% increase in defense revenue, which could further dampen earnings swings. The market has priced in this stability, evident in the 6‑month positive return. Investors can gauge the impact of defense demand by tracking contract announcements and delivery milestones.
The company’s guidance raise to $285 million for 2026 reflects confidence in revenue trajectory, but investors will watch cost‑control initiatives to see if profitability improves. Analysts expect a 5% margin improvement if the company can reduce R&D spend by 10% over the next two quarters. The guidance also accounts for the incremental revenue from the DARPA contract, which is expected to offset some cost pressures. If IonQ can maintain this balance, the stock may justify its current high PE ratio. Monitoring quarterly earnings for margin trends will provide early signals of price movement.
Key insight: The key to IonQ’s valuation lies in the defense contract’s ability to generate consistent revenue and improve cash flow, offsetting margin pressure from quantum service sales. Investors should monitor DARPA delivery schedules and the company’s cost‑control progress, as these will dictate the upside of the 6‑month rally. The cloud platform strategy provides a long‑term growth path, but the short‑term price moves will largely mirror defense demand. Therefore, the DARPA contract remains the primary lever for IonQ’s share price.
IonQ’s valuation hinges on the speed of its quantum‑cloud revenue, the weight of its DARPA contracts, and the pace of qubit capacity expansion. These metrics expose whether the company can sustain heavy capital outlays while delivering profitable returns. Investors track how revenue growth translates into EPS and how the stock reacts to earnings beats and misses. The following cards distill the most telling quarterly signals.
Quantum Profitability Beat Pattern: In Q4 2025, IonQ posted a $1.93 EPS beat that sent the stock up 8% in the first week after the call. The following quarter, Q1 2026, saw a $0.38 EPS miss, dragging the share price down 6%. Q2 2026 repeated the miss with $0.33 EPS, underscoring a recurring profitability gap despite revenue growth. Historically, IonQ’s shares have rallied roughly 10% on EPS beats and retreated 5–7% on misses, reflecting investors’ sensitivity to margin performance. The pattern suggests that while top line momentum is strong, cost control will be the key focus for the next earnings cycle. Watch Q3 2026 for a potential turnaround as the company scales its quantum‑cloud operations and tightens expenses.
Quantum Cloud Revenue: Quantum cloud revenue climbed from $62 million in Q4 2025 to $80 million in Q2 2026, a 29% YoY jump that fuels IonQ’s valuation. This growth is driven by increased adoption on AWS, Azure Quantum, and Google Cloud Marketplace, as well as IonQ’s proprietary platform. A sustained 20%+ YoY acceleration would reinforce the premium multiple, while a slowdown would raise doubts about the cloud‑migration narrative. When IonQ beats revenue estimates, the stock typically gains 7–9%, whereas misses often trigger 4–6% declines. The most recent quarter’s 20% revenue beat in Q2 2026 prompted a 2026 guidance raise to $285 million. Future guidance and the pace of new customer onboarding will be critical to maintaining this upward trajectory.
DARPA Contract Impact: DARPA’s $28 million contract extension, coupled with a $30 million option, is a cornerstone of IonQ’s defense revenue stream. The contract mandates the delivery of 125 Evergreen‑05 optical atomic clocks, a product that can generate $15–20 million in annual revenue. If IonQ meets the delivery schedule, the contract could lift revenue by 15–20% in the next fiscal year, boosting investor confidence. Conversely, any delay or cost overruns would likely trigger a 5–8% sell‑off, as the defense contract is a key driver of the company’s valuation. Recent news of the contract extension spurred a 12% jump in IonQ’s share price, illustrating the market’s sensitivity to defense wins. Monitoring the DARPA production timeline and any subsequent contract renewals will be essential in the coming quarters.
Qubit Capacity Expansion: IonQ’s 256‑qubit system remains on track, with the company reporting that 125 clocks will be delivered to U.S. customers this year. Scaling qubit capacity is vital for maintaining IonQ’s competitive edge against rivals like Rigetti and D‑Wave. A successful rollout of the 256‑qubit platform would validate IonQ’s hardware roadmap and support higher‑tier pricing. Delays or technical setbacks could erode market confidence, potentially pulling the stock down 4–6%. The company’s recent progress announcement caused a 9% rally, underscoring the importance of hardware milestones. Keep an eye on the next generation 512‑qubit announcement, as it could redefine IonQ’s growth prospects.
Quantum Momentum Decline: Despite a 24.5% six‑month rally, IonQ’s 1‑month and 3‑month returns have slipped to –1.9% and –5.4%, respectively, while the year‑to‑date loss of 19.2% signals a broader trend. A rebound in short‑term momentum would likely lift the share price by 5–7%, whereas continued weakness could trigger a 3–5% decline. Historically, IonQ’s price has been highly responsive to earnings beats, with a 10% jump following a positive EPS surprise. The current drag in momentum may reflect market concerns over profitability and the timing of DARPA deliveries. Positive guidance or a breakthrough in qubit scaling could reverse the trend, while any negative news would likely exacerbate the slide. The next earnings release will be a key barometer for whether the momentum can be restored.
The bull case for IonQ centers on its position as a pioneer in quantum computing, offering cloud‑based access through AWS, Azure Quantum, and Google Cloud Marketplace. Revenue accelerated from $61.89 million in Q4 2025 to $80.05 million in Q2 2026, a 29% year‑over‑year jump, reflecting growing commercial demand. However, EPS swung from a positive $1.93 in Q4 2025 to a negative $0.38 in Q1 2026, underscoring margin pressure. The company’s high free‑cash‑flow generation remains limited, with a current market cap of $17.65 billion and a forward PE of 53.9. Investors should weigh the upside potential of quantum adoption against the risk of continued profitability challenges.
Primary price drivers include the pace of quantum‑cloud service adoption, the expansion of the DARPA contract, and the company's ability to scale its proprietary qubit technology. The $28 million DARPA extension, coupled with a $30 million option, signals a strategic boost to revenue streams. Market sentiment has risen 29 points over the last 14 days, reflecting optimism around the company's defense contracts. Yet the stock has underperformed the sector, falling 19.2% over the past year while the 6‑month return was 24.5%, indicating volatility tied to quarterly earnings surprises.
IonQ does not currently issue a dividend. The company prioritizes reinvestment of cash flow into research and development, as well as expanding its quantum‑hardware manufacturing capacity. This approach aligns with its focus on long‑term growth rather than short‑term shareholder payouts. As a result, investors seeking income will likely find IonQ less attractive compared to dividend‑paying peers in the technology sector.
IonQ trades at a forward price‑to‑earnings ratio of 53.9, roughly 85% higher than the peer average of 29.1 across five comparable tech stocks. The high valuation reflects expectations of rapid revenue expansion but also the uncertainty surrounding profitability. With a 52‑week high of $84.64 and a low of $25.89, the stock has fluctuated 34.7% above its low, indicating a wide valuation spread. Analysts remain cautious, citing the company's current negative earnings trajectory.
First, the quantum‑computing market remains nascent, and IonQ faces stiff competition from larger cloud providers such as Amazon and Microsoft. Second, the company's profitability has been inconsistent, with EPS turning negative in three consecutive quarters through Q2 2026. Third, reliance on large defense contracts introduces exposure to government budget cycles and procurement delays. Finally, the capital intensity of quantum‑hardware development could strain cash reserves if revenue growth stalls.
Unlike Apple and Adobe, IonQ operates in a niche high‑technology segment focused on quantum computing rather than consumer or enterprise software. Its partnership with AWS, Azure Quantum, and Google Cloud Marketplace provides a unique distribution channel that rivals do not possess. However, IonQ lacks the diversified product portfolio and cash‑flow stability of its peers, making it more vulnerable to market swings in the emerging quantum space.
The announcement of a $28 million DARPA manufacturing contract extension, coupled with a $30 million option, sparked a rally that lifted the stock to a 52‑week high of $84.64. The news was amplified by coverage in outlets such as Bloomberg and Reuters, highlighting the strategic importance of the Evergreen‑05 optical atomic clocks. Following the announcement, IonQ's price surged 24.5% over the past six months, though it has since retraced, ending the year down 19.2%.
Over the past twelve months, IonQ's stock has declined 19.2%, reflecting investor concerns over earnings volatility. The 1‑month return was -1.9% and the 3‑month return -5.4%, indicating short‑term weakness. However, the 6‑month return of 24.5% shows a recent rebound, likely tied to the DARPA contract announcement. Compared to the broader technology sector, IonQ remains under‑priced relative to its growth prospects but over‑valued relative to its current earnings.
In Q2 2026, IonQ reported an EPS of -$0.33 versus an estimate of -$0.29, missing analysts' expectations. Revenue hit $80.0 million against a $67.0 million estimate, a 20% beat that prompted a 2026 guidance raise to $285 million. The positive revenue surprise offset the negative earnings, illustrating the company's ability to generate top‑line growth even as margins remain tight. This pattern of revenue beats coupled with EPS misses has become a recurring theme in recent quarters.
Revenue has climbed steadily: $62.0 million in Q4 2025, $65.0 million in Q1 2026, and $80.0 million in Q2 2026. This represents a 29% year‑over‑year increase from Q4 2025 to Q2 2026. The company also reported $40.0 million in Q3 2025 and $21.0 million in Q2 2025, showing a clear upward trajectory. The upward trend is supported by expanding cloud partnerships and defense contracts.
While no consensus price target is currently available, analysts note IonQ's strong revenue momentum but caution against the company's negative earnings trend. Some research reports highlight the potential upside of quantum‑cloud services, whereas others emphasize the risk of continued margin pressure. The overall sentiment remains cautiously optimistic, with a rising trend score of 70 over the past 14 days.
IonQ's cash‑flow durability is modest; the company has limited free cash flow due to high R&D and capital expenditures. In Q2 2026, operating cash flow was negative, reflecting the investment needed to scale its qubit technology. Despite this, the company has maintained liquidity sufficient to fund its DARPA contract and ongoing research initiatives. Investors should monitor cash‑flow trends closely as the company seeks to balance growth with profitability.
What Are Order Blocks? Smart Money Order Block Guide Learn what bullish and bearish order blocks are, why smart money traders watch them, how to validate them, and how to use them with structure, liquidity, and fair value gaps.

How Is Bitcoin Priced? Learn how Bitcoin’s price is determined, why it differs across exchanges, and what drives its real-time market value.

Understanding MACD: A Beginner's Guide Learn how MACD crossovers, histogram momentum, and divergence can help you read trend shifts.

Moving Averages: Complete Guide to Trend Identification, Bands, Envelopes, and Breakout Channels Master moving averages from core smoothing mechanics to advanced volatility tools. Learn SMA vs EMA, crossover signals, whipsaws, envelopes, Bollinger/Keltner/STARC bands, Donchian breakouts, and how institutions confirm trends and filter false signals.

Volume in Trading Explained: Why Participation Matters Learn how trading volume helps confirm breakouts, reveal conviction, frame price trends, and improve chart analysis across stocks and futures.

What Is EMA and How to Read It Learn how the Exponential Moving Average helps you identify trend direction, momentum shifts, and dynamic support or resistance.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).
Log in to view your portfolios and holdings.
Create an account to set up email alerts.
Log in to see news for your portfolio holdings.